SOX17 and neoplasm: Kaplan–Meier survival curves indicated that the overall and disease‐free survival rates of patients with tumor endothelial SOX17 immunoreactivity were more favorable than those of SOX17‐negative groups but without statistically significant differences (Figure 4).